Next Article in Journal
Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects
Next Article in Special Issue
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
Previous Article in Journal
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition
Previous Article in Special Issue
Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(8), 1813; https://doi.org/10.3390/cancers13081813
Action Date Notes Link
article xml file uploaded 10 April 2021 11:58 CEST Original file -
article xml uploaded. 10 April 2021 11:58 CEST Update -
article pdf uploaded. 10 April 2021 11:58 CEST Version of Record -
article supplementary file uploaded. 10 April 2021 11:58 CEST - https://www.mdpi.com/2072-6694/13/8/1813#supplementary
article html file updated 10 April 2021 11:59 CEST Original file -
article xml file uploaded 10 April 2021 12:46 CEST Update -
article xml uploaded. 10 April 2021 12:46 CEST Update -
article pdf uploaded. 10 April 2021 12:46 CEST Updated version of record https://www.mdpi.com/2072-6694/13/8/1813/pdf
article html file updated 10 April 2021 12:48 CEST Update -
article xml file uploaded 19 April 2021 07:40 CEST Update -
article xml uploaded. 19 April 2021 07:40 CEST Update https://www.mdpi.com/2072-6694/13/8/1813/xml
article html file updated 19 April 2021 07:41 CEST Update -
article html file updated 4 August 2021 22:53 CEST Update -
article html file updated 4 August 2021 23:12 CEST Update -
article html file updated 25 July 2022 11:38 CEST Update https://www.mdpi.com/2072-6694/13/8/1813/html
Back to TopTop